US9283217B2ActiveUtilityA1

Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

90
Assignee: ALLERGAN INCPriority: Nov 10, 2011Filed: Mar 14, 2013Granted: Mar 15, 2016
Est. expiryNov 10, 2031(~5.3 yrs left)· nominal 20-yr term from priority
A61K 9/0014A61K 9/0019A61K 31/4709
90
PatentIndex Score
6
Cited by
21
References
4
Claims

Abstract

The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1H-Imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method for treating a skin condition selected from the group consisting of sunburn, erythema of the skin, and cutaneous hyperactivity with dilation of blood vessels of the skin, the method comprising administering to a patient in need thereof a pharmaceutical composition comprising a therapeutically effective amount of (S)-(+)-7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydroquinoline, or an individual tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing. 
     
     
       2. The method according to  claim 1 , wherein the condition is sunburn. 
     
     
       3. The method according to  claim 1 , wherein the condition is erythema of the skin. 
     
     
       4. The method according to  claim 1 , wherein the condition is cutaneous hyperactivity with dilation of blood vessels of the skin.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.